Literature DB >> 27903072

A 5' Noncoding Exon Containing Engineered Intron Enhances Transgene Expression from Recombinant AAV Vectors in vivo.

Jiamiao Lu1,2, James A Williams3, Jeremy Luke3, Feijie Zhang1,2, Kirk Chu1,2, Mark A Kay1,2.   

Abstract

We previously developed a mini-intronic plasmid (MIP) expression system in which the essential bacterial elements for plasmid replication and selection are placed within an engineered intron contained within a universal 5' UTR noncoding exon. Like minicircle DNA plasmids (devoid of bacterial backbone sequences), MIP plasmids overcome transcriptional silencing of the transgene. However, in addition MIP plasmids increase transgene expression by 2 and often >10 times higher than minicircle vectors in vivo and in vitro. Based on these findings, we examined the effects of the MIP intronic sequences in a recombinant adeno-associated virus (AAV) vector system. Recombinant AAV vectors containing an intron with a bacterial replication origin and bacterial selectable marker increased transgene expression by 40 to 100 times in vivo when compared with conventional AAV vectors. Therefore, inclusion of this noncoding exon/intron sequence upstream of the coding region can substantially enhance AAV-mediated gene expression in vivo.

Entities:  

Keywords:  AAV vectors; enhance transgene expression; intron; mini-intronic plasmid; miniorigins

Mesh:

Substances:

Year:  2017        PMID: 27903072      PMCID: PMC5278795          DOI: 10.1089/hum.2016.140

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  25 in total

1.  Promoter proximal splice sites enhance transcription.

Authors:  Andre Furger; Justin M O'Sullivan; Alexandra Binnie; Barbara A Lee; Nick J Proudfoot
Journal:  Genes Dev       Date:  2002-11-01       Impact factor: 11.361

2.  Predictive identification of exonic splicing enhancers in human genes.

Authors:  William G Fairbrother; Ru-Fang Yeh; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2002-07-11       Impact factor: 47.728

3.  Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo.

Authors:  Zhi-Ying Chen; Cheng-Yi He; Mark A Kay
Journal:  Hum Gene Ther       Date:  2005-01       Impact factor: 5.695

4.  Minimal size MIDGE vectors improve transgene expression in vivo.

Authors:  Frank Schakowski; Marcus Gorschlüter; Peter Buttgereit; Angela Märten; Marie V Lilienfeld-Toal; Claas Junghans; Matthias Schroff; Sven A König-Merediz; Carsten Ziske; John Strehl; Tilman Sauerbruch; Burghardt Wittig; Ingo G H Schmidt-Wolf
Journal:  In Vivo       Date:  2007 Jan-Feb       Impact factor: 2.155

Review 5.  Immune responses to AAV in clinical trials.

Authors:  Federico Mingozzi; Katherine A High
Journal:  Curr Gene Ther       Date:  2007-10       Impact factor: 4.391

6.  A new DNA vehicle for nonviral gene delivery: supercoiled minicircle.

Authors:  A M Darquet; B Cameron; P Wils; D Scherman; J Crouzet
Journal:  Gene Ther       Date:  1997-12       Impact factor: 5.250

7.  G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection.

Authors:  A J McCullough; S M Berget
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

Review 8.  Immune responses to AAV vectors: overcoming barriers to successful gene therapy.

Authors:  Federico Mingozzi; Katherine A High
Journal:  Blood       Date:  2013-04-17       Impact factor: 22.113

9.  Introns increase transcriptional efficiency in transgenic mice.

Authors:  R L Brinster; J M Allen; R R Behringer; R E Gelinas; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

10.  A robust system for production of minicircle DNA vectors.

Authors:  Mark A Kay; Cheng-Yi He; Zhi-Ying Chen
Journal:  Nat Biotechnol       Date:  2010-11-21       Impact factor: 54.908

View more
  6 in total

1.  Fludarabine increases nuclease-free AAV- and CRISPR/Cas9-mediated homologous recombination in mice.

Authors:  Shinnosuke Tsuji; Calvin J Stephens; Giulia Bortolussi; Feijie Zhang; Gabriele Baj; Hagoon Jang; Gustavo de Alencastro; Andrés F Muro; Katja Pekrun; Mark A Kay
Journal:  Nat Biotechnol       Date:  2022-04-07       Impact factor: 68.164

Review 2.  Progress of Transposon Vector System for Production of Recombinant Therapeutic Proteins in Mammalian Cells.

Authors:  Mian Wei; Chun-Liu Mi; Chang-Qin Jing; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-04

3.  Exploring the role of NCCR variation on JC polyomavirus expression from dual reporter minicircles.

Authors:  Anne-Sophie L'Honneur; Hervé Leh; Fanny Laurent-Tchenio; Uriel Hazan; Flore Rozenberg; Stéphanie Bury-Moné
Journal:  PLoS One       Date:  2018-06-26       Impact factor: 3.240

4.  Optimization of miR-22 expression cassette for rAAV delivery on diabetes.

Authors:  Li Yang; Wenya Du; Zhaoyue Zheng; Li Wang; Lin Xiao; Qingzhe Yang; Qiukui Hao; Jiao Zhou; Jintao Du; Jun Li; C Alexander Valencia; Birong Dong; Hoi Yee Chow; Xianghui Fu; Biao Dong
Journal:  Mol Biomed       Date:  2022-01-05

Review 5.  Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.

Authors:  Julien Baruteau; Simon N Waddington; Ian E Alexander; Paul Gissen
Journal:  J Inherit Metab Dis       Date:  2017-05-31       Impact factor: 4.982

Review 6.  Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays.

Authors:  Thilo M Buck; Jan Wijnholds
Journal:  Int J Mol Sci       Date:  2020-06-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.